ArticleMolecular cancer therapeutics2019

A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted Therapeutics.

Jelmar Quist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.